178 related articles for article (PubMed ID: 17440966)
41. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
[TBL] [Abstract][Full Text] [Related]
42. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
43. Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells.
Yasmin T; Takahashi-Yanaga F; Mori J; Miwa Y; Hirata M; Watanabe Y; Morimoto S; Sasaguri T
Biochem Biophys Res Commun; 2005 Dec; 338(2):903-9. PubMed ID: 16243295
[TBL] [Abstract][Full Text] [Related]
44. Increasing expression of GST-pi MIF, and ID1 genes in chemoresistant prostate cancer cells.
Yu DS; Hsieh DS; Chang SY
Arch Androl; 2006; 52(4):275-81. PubMed ID: 16728343
[TBL] [Abstract][Full Text] [Related]
45. Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
Wang H; Han H; Von Hoff DD
Cancer Res; 2006 Oct; 66(19):9722-30. PubMed ID: 17018631
[TBL] [Abstract][Full Text] [Related]
46. Analysis of gene expression during staurosporine-induced neuronal differentiation of human prostate cancer cells.
Shimizu T; Okayama A; Inoue T; Takeda K
Oncol Rep; 2005 Aug; 14(2):441-8. PubMed ID: 16012728
[TBL] [Abstract][Full Text] [Related]
47. TGFBR3 loss and consequences in prostate cancer.
Sharifi N; Hurt EM; Kawasaki BT; Farrar WL
Prostate; 2007 Feb; 67(3):301-11. PubMed ID: 17192875
[TBL] [Abstract][Full Text] [Related]
48. Expression of G protein-coupled receptor 19 in human lung cancer cells is triggered by entry into S-phase and supports G(2)-M cell-cycle progression.
Kastner S; Voss T; Keuerleber S; Glöckel C; Freissmuth M; Sommergruber W
Mol Cancer Res; 2012 Oct; 10(10):1343-58. PubMed ID: 22912338
[TBL] [Abstract][Full Text] [Related]
49. Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis.
Schlomm T; Luebke AM; Sültmann H; Hellwinkel OJ; Sauer U; Poustka A; David KA; Chun FK; Haese A; Graefen M; Erbersdobler A; Huland H
Int J Oncol; 2005 Sep; 27(3):713-20. PubMed ID: 16077921
[TBL] [Abstract][Full Text] [Related]
50. Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners.
Iwanaga R; Komori H; Ishida S; Okamura N; Nakayama K; Nakayama KI; Ohtani K
Oncogene; 2006 Mar; 25(12):1786-98. PubMed ID: 16288221
[TBL] [Abstract][Full Text] [Related]
51. Effect of procathepsin D activation peptide on gene expression of breast cancer cells.
Benes P; Vashishta A; Saraswat-Ohri S; Fusek M; Pospisilova S; Tichy B; Vetvicka V
Cancer Lett; 2006 Jul; 239(1):46-54. PubMed ID: 16168559
[TBL] [Abstract][Full Text] [Related]
52. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma.
Fritzsche S; Kenzelmann M; Hoffmann MJ; Müller M; Engers R; Gröne HJ; Schulz WA
Endocr Relat Cancer; 2006 Sep; 13(3):839-49. PubMed ID: 16954433
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of cell cycle regulatory molecules and evidence for a "cyclin switch" during progression of prostate cancer.
Maddison LA; Huss WJ; Barrios RM; Greenberg NM
Prostate; 2004 Mar; 58(4):335-44. PubMed ID: 14968434
[TBL] [Abstract][Full Text] [Related]
54. Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells.
Yoshiko S; Hoyoku N
In Vivo; 2007; 21(2):305-9. PubMed ID: 17436581
[TBL] [Abstract][Full Text] [Related]
55. Cellular expression, localization and interactions of the product of the human MOST-1 gene associated with breast and prostate cancers.
Tan JM; Chow VT
Int J Oncol; 2007 Jan; 30(1):81-9. PubMed ID: 17143515
[TBL] [Abstract][Full Text] [Related]
56. Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.
Zhu Q; Yang J; Han S; Liu J; Holzbeierlein J; Thrasher JB; Li B
Prostate; 2011 Jun; 71(8):835-45. PubMed ID: 21456066
[TBL] [Abstract][Full Text] [Related]
57. [Analysis of gene expression profile of G1/S transition in gastric cancer cell cycle].
Lan B; Liu BY; Zhang J; Wang KK; Chen XH; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):229-33. PubMed ID: 16167235
[TBL] [Abstract][Full Text] [Related]
58. Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and doxorubicin.
Hao H; Dong YB; Bowling MT; Zhou HS; McMasters KM
Anticancer Res; 2006; 26(3A):1947-56. PubMed ID: 16827129
[TBL] [Abstract][Full Text] [Related]
59. [Transfection of tumor metastasis suppressor gene nm23-H1 can up-regulate the activity of GSK-3β in human high-metastasis large cell lung cancer cell line L9981].
Fu J; Zhou Q; Zhu W; Wang Y; Chen X; Che G; Nie Q; Li D; Liu L; Li Y
Zhongguo Fei Ai Za Zhi; 2004 Apr; 7(2):81-5. PubMed ID: 21214996
[TBL] [Abstract][Full Text] [Related]
60. Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray.
Li Y; Li X; Hussain M; Sarkar FH
Neoplasia; 2004; 6(2):158-67. PubMed ID: 15140405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
